Sentences with phrase «more human embryonic stem»

Francis Collins, the director of the National Institutes of Health, approved eight more human embryonic stem cell lines for federal funding earlier this week.

Not exact matches

While scientists have previously had success in 3D printing a range of human stem cell cultures developed from bone marrow or skin cells, a team from Scotland's Heriot - Watt University claims to be the first to print the more delicate, yet more flexible, human embryonic stem cells (hESCs).

The vote will have little direct impact on human embryonic stem cell research, but the potential threat to reproductive technology and abortion rights is more immediate

Human embryonic stem cell (hESC) research had been backed by federal funds for more than a decade, but a surprise August injunction by a federal judge threw the field's future into question.

Lamberth interprets that to include funding of research on human embryonic stem cells more broadly, even though the Department of Health and Human Services and several presidential Administrations have not aghuman embryonic stem cells more broadly, even though the Department of Health and Human Services and several presidential Administrations have not agHuman Services and several presidential Administrations have not agreed.

Although primed, post-implantation embryonic stem cells can still turn into any type of human cell, they are more difficult to work with than the pre-implantation, naive cells.

Because fertilized human embryos are far more accessible than unfertilized eggs, which can not be frozen and stored, extending the result to humans could lower the practical barriers against creating human embryonic stem cells to study and potentially treat disease.

«We are in an era where the primary issues are not federal funding for human embryonic stem cell research,» wrote CAMR President Amy Comstock Rick, who is also CEO of the Parkinson's Action Network, in an e-mail to the more than 100 patient advocacy, scientific, and other groups that belong to CAMR.

«Though the degree to which human embryonic stem cells possess this feature is not entirely clear, by understanding how another complex organism's genome works we ultimately learn more about how our own genome works,» said Zhou.

A bill that would allow federal funding for derivation of new lines of human embryonic stem (ES) cells passed the U.S. House of Representatives yesterday 238 to 194 after more than four hours of debate.

It has taken more than five years of graft, but at long last approval has been given for the first clinical trial using human embryonic stem cells (hESCs).

John Gearhart, one of the first scientists to isolate, in 1998, human embryonic stem cells, also downplayed the therapeutic value of human cloning, saying «the more we learn about reprogramming, the more I think IPS will be the one of choice.»

In the meantime a large number of federally funded human embryonic stem cell projects have been placed on hold, and even more are potentially at risk.

Two recent developments involving the California Institute for Regenerative Medicine (CIRM) again serve to underscore the reality that adult and other non-embryonic avenues of stem cell research are advancing at a far more dramatic pace toward providing actual therapeutic benefits for patients than is human embryonic stem cell research (hESCR).

The stem cell research community hopes that as more is understood about STAP cells, they will join embryonic stem and iPS cells as another reprogramming tool for use in their collective quest to understand and treat human disease.

For more on human embryonic stem cells, see Teisha Rowland's «All Things Stem Cell post on «Induced Pluripotent Stem Cells: A New Stem Cell Line with a Long History,» The National Institute of Health's Stem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell Glossstem cells, see Teisha Rowland's «All Things Stem Cell post on «Induced Pluripotent Stem Cells: A New Stem Cell Line with a Long History,» The National Institute of Health's Stem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell GlossStem Cell post on «Induced Pluripotent Stem Cells: A New Stem Cell Line with a Long History,» The National Institute of Health's Stem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell GlossStem Cells: A New Stem Cell Line with a Long History,» The National Institute of Health's Stem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell GlossStem Cell Line with a Long History,» The National Institute of Health's Stem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell GlossStem Cell FAQs, or, for a visual explanation of terms used, see All Things Stem Cell's Visual Stem Cell GlossStem Cell's Visual Stem Cell GlossStem Cell Glossary.

A new study confirms a seemingly obvious assumption about human embryonic stem cell research: Countries with fewer restrictions on research outperform countries with more restrictions.

The latest round of CIRM grants, totaling more than $ 50 million, will finance construction of shared research laboratories at 17 academic and non-profit institutions for the culture of human embryonic stem cells (hESCs), particularly those that fall outside federal guidelines.

After only 10 days — instead of the more typical three to four weeks — one out of 100 hundred cells grew into a tiny colony with all the markings of a typical human embryonic stem cell colony.

Starting with transplants of human oligodendrocytes in the late 1980s [40], and more recently with populations of human oligodendrocyte progenitor cells isolated from the developing or adult CNS, or from human embryonic stem cells, it has been possible to generate extensive myelination upon transplantation into spinal cord injury or into congenital mouse models of hypomyelination [41]--[48].

There are many more differentiated cells in the human body than stem cells, embryonic or adult.

Embryonic» and «senescent» aren't supposed to go together any more than «good» and «grief» or other oxymorons, which is why biologist Robert Lanza was «devastated» when he saw what was happening with the human stem cells he and colleagues were trying to grow.

The biologist doing more than anyone else to stir the debate is University of Wisconsin researcher James Thomson, who co-discovered human embryonic stem cells a decade ago, in November 1998.

The challenge takes on even more urgency with recent developments, including a federal administration now more open to exploring the potential of stem cells, the recent FDA approval of a human trial involving embryonic stem cells, as well as the reported case of a young boy who developed a brain tumor four years after receiving a stem - cell treatment for a rare genetic disorder.

In April 2004, more than 200 members of the U.S. House of Representatives sent President Bush a letter, asking him to increase the number of human embryonic stem cell lines that should be eligible for public funding.

Less than a year after a Wisconsin team helped discover a major alternative to human embryonic stem cells, the Madison scientists say more than 800 labs have begun using the approach, suggesting that many stem - cell researchers are starting to move beyond controversial embryonic sources for their work.

But even before the cash spigot opens, the government may close it — or even try to limit research on human embryonic stem cells, the more promising and controversial type of stem cell.

* The role of the US in global efforts to address pollutants that are broadly dispersed across national borders, such as greenhouse gasses, persistent organic pollutants, ozone, etc...; * How they view a president's ability to influence national science policy in a way that will persist beyond their term (s), as would be necessary for example to address global climate change or enhancement of science education nationwide; * Their perspective on the relative roles that scientific knowledge, ethics, economics, and faith should play in resolving debates over embryonic stem cell research, evolution education, human population growth, etc... * What specific steps they would take to prevent the introduction of political or economic bias in the dissemination and use of scientific knowledge; * (and many more...)

However welcome the recent announcement that a team of scientists based at Newcastle University, has grown a section of human liver using stem cells from umbilical cords, rather than from the more controversial source of embryonic stem cells, and whatever the eventual promise or potential of harvesting organs for transplantation from genetically modified pigs, the benefits of either of these two pioneering techniques to currently dying / suffering patients, remain both elusive and distant.